Xu W[au] - Search Results

Year	Number of Results
1979	2
1980	1
1981	1
1982	2
1983	5
1984	9
1985	21
1986	19
1987	7
1988	20
1989	29
1990	21
1991	32
1992	25
1993	37
1994	46
1995	66
1996	62
1997	62
1998	73
1999	91
2000	84
2001	112
2002	115
2003	171
2004	190
2005	242
2006	321
2007	410
2008	520
2009	638
2010	721
2011	809
2012	938
2013	1120
2014	1256
2015	1448
2016	1542
2017	1719
2018	1902
2019	2215
2020	2622
2021	2854
2022	324

1

Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.

Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, Li X, Xu W, Mesa-Eguiagaray I, Rostron J, Theodoratou E, Zhang X, Motee A, Liew D, Ilic D. Talic S, et al. Among authors: xu w. BMJ. 2021 Nov 17;375:e068302. doi: 10.1136/bmj-2021-068302. BMJ. 2021. PMID: 34789505 Free article.

2

African Swine Fever Virus pI215L Negatively Regulates cGAS-STING Signaling Pathway through Recruiting RNF138 to Inhibit K63-Linked Ubiquitination of TBK1.

Huang L, Xu W, Liu H, Xue M, Liu X, Zhang K, Hu L, Li J, Liu X, Xiang Z, Zheng J, Li C, Chen W, Bu Z, Xiong T, Weng C. Huang L, et al. Among authors: xu w. J Immunol. 2021 Dec 1;207(11):2754-2769. doi: 10.4049/jimmunol.2100320. Epub 2021 Nov 10. J Immunol. 2021. PMID: 34759016

3

On-Surface Synthesis of sp-Carbon Nanostructures.

Shang L, Kang F, Gao W, Zhou Z, Xu W. Shang L, et al. Among authors: xu w. Nanomaterials (Basel). 2021 Dec 31;12(1):137. doi: 10.3390/nano12010137. Nanomaterials (Basel). 2021. PMID: 35010087 Free PMC article. Review.

4

Regulatory perspectives of combination products.

Tian J, Song X, Wang Y, Cheng M, Lu S, Xu W, Gao G, Sun L, Tang Z, Wang M, Zhang X. Tian J, et al. Among authors: xu w. Bioact Mater. 2021 Sep 7;10:492-503. doi: 10.1016/j.bioactmat.2021.09.002. eCollection 2022 Apr. Bioact Mater. 2021. PMID: 34901562 Free PMC article. Review.

5

Targeting PI3K/Akt signal transduction for cancer therapy.

He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. He Y, et al. Among authors: xu ww. Signal Transduct Target Ther. 2021 Dec 16;6(1):425. doi: 10.1038/s41392-021-00828-5. Signal Transduct Target Ther. 2021. PMID: 34916492 Free PMC article. Review.

6

An Update on the Relationship of SARS-CoV-2 and Male Reproduction.

Guo J, Sheng K, Wu S, Chen H, Xu W. Guo J, et al. Among authors: xu w. Front Endocrinol (Lausanne). 2021 Nov 23;12:788321. doi: 10.3389/fendo.2021.788321. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34887838 Free PMC article. Review.

7

Exosomes: Emerging Cell-Free Based Therapeutics in Dermatologic Diseases.

Shi H, Wang M, Sun Y, Yang D, Xu W, Qian H. Shi H, et al. Among authors: xu w. Front Cell Dev Biol. 2021 Oct 14;9:736022. doi: 10.3389/fcell.2021.736022. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34722517 Free PMC article. Review.

8

The emerging role of extracellular vesicles in retinal diseases.

Sun F, Xu W, Qian H. Sun F, et al. Among authors: xu w. Am J Transl Res. 2021 Dec 15;13(12):13227-13245. eCollection 2021. Am J Transl Res. 2021. PMID: 35035672 Free PMC article. Review.

9

[Roles of nociceptors in acupoint sensitization: recent advances].

Xu WJ, Cui X, Liu K, Zhu B, Gao XY. Xu WJ, et al. Zhen Ci Yan Jiu. 2021 Dec 25;46(12):1048-56. doi: 10.13702/j.1000-0607.20210313. Zhen Ci Yan Jiu. 2021. PMID: 34970883 Review. Chinese.

10

Targeted RNA editing: novel tools to study post-transcriptional regulation.

Xu W, Biswas J, Singer RH, Rosbash M. Xu W, et al. Mol Cell. 2022 Jan 20;82(2):389-403. doi: 10.1016/j.molcel.2021.10.010. Epub 2021 Nov 4. Mol Cell. 2022. PMID: 34739873 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results